Immediate release fixed-dose combination of memantine and donepezil

The present disclosure relates immediate release fixed-dosed combination pharmaceutical composition comprising the active pharmaceutical ingredients Memantine and Donepezil for the treatment of moderate to severe Alzheimer's disease.

Saved in:
Bibliographic Details
Main Authors Silva Serra Joao Pedro, Pardal Filipe Augusto Eugenio, Silva Marques Da Costa Ricardo Manuel, Oliviera Machuco Estevens Maria Catarina
Format Patent
LanguageEnglish
Hebrew
Published 01.01.2022
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates immediate release fixed-dosed combination pharmaceutical composition comprising the active pharmaceutical ingredients Memantine and Donepezil for the treatment of moderate to severe Alzheimer's disease.
Bibliography:Application Number: IL20210288505